Cerecor Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CERC research report →
Price Chart
About the company
Cerecor Inc. operates as a biopharmaceutical firm dedicated to the discovery and marketing of therapeutic solutions, primarily addressing rare pediatric and orphan diseases. The company maintains an active pipeline, including: Inherited Metabolic Disorders: Advancing CERC-801 and CERC-802, both of which have successfully completed Phase I clinical trials, alongside CERC-803.
- CEO
- Michael Cola
- IPO
- 2015
- Employees
- 30
- HQ
- Rockville, MD, US
Get TickerSpark's AI analysis on CERC
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Similar companies
Peers in the same neighborhood.
- Market Cap
- $38.63M
- P/E
- -0.65
- PEG
- 0.01
- P/S
- -184.83
- P/B
- 0.28
- EV/EBITDA
- 0.62
- Div Yield
- 0.00%
- Gross Margin
- 64.11%
- Op Margin
- 43712.44%
- Net Margin
- 54297.61%
- ROE
- -65.64%
- ROIC
- -19.44%
Latest fiscal year · YoY change
- Revenue
- $59.00K-86.6%
- Gross Profit
- $0+100.0%
- Op Income
- $-72,925,000
- Net Income
- $-78,259,000-122.8%
- EPS
- $-5.84-74.8%
- OCF Growth
- -4.9%
- FCF Growth
- -4.9%
- 52W High
- $4.50
- 52W Low
- $1.98
- 50D MA
- $2.87
- 200D MA
- $3.04
- Beta
- 1.44
- RSI (14)
- 52
- Avg Volume
- 639.17K
No earnings-call transcripts are available for CERC yet.
- Free Float
- 34.2%
- Shares Outstanding
- 13.18M
- Float Shares
- 4.50M
of shares held by institutions
68 13F filers
Buy/sell ratio 0.00. Sells can include pre-scheduled 10b5-1 plan sales, not just discretionary selling.
Top institutional holders
Largest 13F positions, with quarter-over-quarter change.
| Holder | Shares | Δ Quarter |
|---|---|---|
| Virtu Kcg Holdings LLC | 40.20K | ▼ 4.26K |
| Commonwealth Equity Services, Inc | 13.01K | 0 |
| Blackrock Fund Advisors | 1.93K | ▲ 540 |
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Aug 18, 21 | ARMISTICE CAPITAL, LLC | buy | 20,000 |
| Aug 16, 21 | ARMISTICE CAPITAL, LLC | buy | 30,000 |
| Jul 1, 21 | COLA MICHAEL F | other | 51,740 |
| Jun 30, 21 | Bruhn Suzanne Louise | other | 3,465 |
| Jun 30, 21 | KAPLAN GILLA | other | 6,353 |
| Jun 30, 21 | Miller Joseph M | other | 4,620 |
| Jun 30, 21 | Persson Magnus | other | 3,985 |
| Jun 15, 21 | Persson Magnus | other | 40,000 |
| Jun 15, 21 | Miller Joseph M | other | 40,000 |
| Jun 15, 21 | Bruhn Suzanne Louise | other | 40,000 |
A “Sell” may be a pre-scheduled 10b5-1 plan sale rather than a discretionary decision — read insider selling with that in mind.
Our CERC coverage
Recent articles, reports, and earnings notes.
No research on CERC yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CERC report →Avalo Therapeutics, Inc. Announces Corporate Name Change from Cerecor Inc.
globenewswire.com · Aug 26
Cerecor Reports Second Quarter 2021 Financial Results and Provides Business Updates
globenewswire.com · Aug 2
Cerecor Announces Drawdown of $10 Million Tranche under its Debt Financing Agreement with Horizon Technology Finance
globenewswire.com · Aug 2
Cerecor's Crohn's Disease Candidate Shows Encouraging Response In Pretreated Patients
benzinga.com · Jul 27
Cerecor Licenses Immune Checkpoint Program from Sanford Burnham Prebys Further Expanding Pipeline of Immunology and Immuno-oncology Targets
globenewswire.com · Jun 23
Top Penny Stocks to Buy Moving in Premarket? Check These 3 Out
pennystocks.com · May 11
Cerecor Shares Gain After FDA Fast Track Review Tag For CERC-002 In Hospitalized COVID-19 Patients
benzinga.com · May 11
Cerecor's investigational COVID-19 therapy gets Fast Track designation from the FDA
marketwatch.com · May 11
Headlines from third-party outlets — TickerSpark isn't affiliated with these sources.